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INTRODUCTION
Frequent colonization of female and male genitourinary
tract by ureaplasmas sometimes hinders evaluation of these
microorganisms as infectious agents. Although Ureaplasma
urealyticum was divided into two biovars and new species Ure-
aplasma parvum was described, additional studies are required
to determine differences in pathogenicity and respective role
of these microorganisms in diseases. Detection of ureaplas-
mas is possible by characteristic growth on appropriate media
and urease activity, but species identification of U. urealyticum
and U. parvum must be demonstrated by molecular methods.
Differentiation between U. parvum and U. urealyticum is very
important, especially for correct interpretation of laboratory
results and evaluation of pathogenicity.
U. parvum includes small genome strains: 0.75-0.76 Mpb
(former biovar 1 of U. urealyticum-serovars 1, 3, 6, and 14).
U. urealyticum includes serovars 2, 4, 5, and 7-13 (former biovar
2) (1-4). Cervical dysplasia is connected with infection with
high-oncogenic types of human papillomavirus (HPV). Dis-
ruption in function of immune mechanisms and inflamma-
tion might be initiated by co-occurrence of bacterial pa-
thogens, including ureaplasmas. The influence of ureaplas-
mas on cytokine concentrations was confirmed with cell cul-
tures in vitro and in vivo, using animal models and human
cervico-vaginal samples (5, 6). Ureaplasmas can also act on
progression of cervical dysplasia, classified with the Bethes-
da System 2001 classification scheme as atypical squamous
cells of undetermined significance (ASCUS), low grade squa-
mous intraepithelial lesions (LSIL), high grade squamous
intraepithelial lesions (HSIL) and cancer (7). 
The aim of this study was to evaluate the occurrence of gen-
ital mycoplasmas, especially U. parvum and U. urealyticum, in
women with ASCUS, LSIL and HSIL, compared to women
with normal cytology in Katowice, southern Poland. 
MATERIALS AND METHODS 
One hundred and eighty two non-pregnant, menstruat-
ing, sexually active women (mean age 39.5 yr), with similar
socio-economic status, who attended Department of Medi-
cal Microbiology of Medical University of Silesia in Katow-
ice for microbiological diagnosis, were included in this study.
They did not use oral or vaginal contraceptives and antibi-
otics/antimycotics within at least 4 weeks before examina-
tion. Cervical swabs were taken from all studied women and
tested for cytology. All cytology results were interpreted by
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Occurrence of Ureaplasma parvum and Ureaplasma urealyticum
in Women with Cervical Dysplasia in Katowice, Poland
The aim of this study was to evaluate the occurrence of genital mycoplasmas, espe-
cially Ureaplasma parvum and Ureaplasma urealyticum, in women with atypical
squamous cells of undetermined significance (ASCUS), low grade squamous intraep-
ithelial lesions (LSIL) and high grade squamous intraepithelial lesions (HSIL), com-
pared to women with normal cytology living in Katowice, Poland. Two sterile swabs
were used to obtain material from the posterior vaginal fornix of 143 women with
squamous intraepithelial lesions and 39 healthy women: first for general bacteriol-
ogy, second for detection of urogenital mycoplasmas using Mycoplasma IST2 kit.
From each positive Mycoplasma IST2 culture DNA was isolated and PCR was per-
formed for identification of U. parvum and U. urealyticum. Mycoplasma IST was
positive in 34.1% cases. Urogenital mycoplasmas were demonstrated in women
with HSIL significantly more often compared to women with LSIL, ASCUS, and with
normal cytology. DNA of U. parvum was demonstrated in majority of Mycoplasma
IST2-positive cases, U. urealyticum DNA-only in 9 (4.9%). Predominance of 3/14
serovars of U. parvum was demonstrated. U. urealyticum biovar 2 was present more
often in women with squamous intraepithelial lesions. 
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two pathologists into normal, ASCUS, LSIL, HSIL, squamous
cell carcinoma (SCC) according to 2001 Betheda System (7).
All women gave informed consent for this study. This study
was approved by Bioethical Committee of Medical Univer-
sity of Silesia NN-6501-246/04. 
Two sterile swabs were used to obtain material from the
posterior vaginal fornix: first for general bacteriology was
cultured on the following agar plates: Columbia blood, Mac-
Conkey, Chapman, Thayer-Martin and Sabouraud, respecti-
vely for streptococci, lactobacilli, Gram-negative rods, staphy-
lococci, gonococci and yeasts. BV-bacterial vaginosis was diag-
nosed by Nugent and Amsel criteria (8, 9).
Isolated microorganisms were identified with morpholog-
ical, biochemical and serological characteristics. Second swab
for detection of urogenital mycoplasmas was cultured using
Mycoplasma IST2 (bioMe@rieux, Marcy-L’etoile, France), accord-
ing to manufacturer’s instructions. For isolation of DNA,
each culture in logarithmic phase of growth was centrifuged
15.000 g for 30 min in 4℃, pellet was twice washed with
PBS and incubated with buffer containing proteinase K. Iso-
lation of DNA was performed with appropriate columns,
using DNeasy Tissue Kit, Qiagen. Cultures of mycoplasmas
in urea-arginine broth and DNAs were stored at -70℃until
used. Two cervical swabs were taken from each of 182 stud-
ied women for the determination of Chlamydia trachomatis
with AMPLICOR C. trachomatis, Roche Molecular Systems,
U.S.A., and high-risk HPV types: 16, 18, 31, 33, 35, 39, 45,
51, 52, 56, 58, 59, and 68 by Amplicor HPV, Roche Molec-
ular System U.S.A., respectively.
PCR identification of ureaplasmas was done according to
Kong et al. (3), using termocycler Genius (Techne, U.K.)
and Taq PCR Master Mix Kit (Qiagen). Primers UMS- 57/
UMA222 and UMS-170/UMA263 were used for identifi-
cation of U. parvum (326 bp) and U. urealyticum (476 bp),
respectively. Amplified products were visualized under UV
light after electrophoresis in 2% agarose gel, containing ethid-
ium bromide (Table 1). The reference strains from American
Type Culture Collection: U. urealyticum ATCC 27618 and
U. parvum ATCC 27815T were used as positive controls. 
Statistical analysis was performed by chi-square test (P<0.05
was statistically significant). 
RESULTS
According to cervix cytology results, the following sub-
groups were identified: 67 women with ASCUS, mean age
40.5 yr; 49 women with LSIL, mean age 36.6 yr; 22 with
HSIL, mean age 34.1 yr; and 39 with normal cytology, mean
age 39 yr; SCC was diagnosed in 5 cases. Presence of urogen-
ital mycoplasmas was confirmed by Mycoplasma IST2 in 62/
182 cases 34.1%. Women with HSIL showed the presence of
urogenital mycoplasmas significantly more often than women
with LSIL (P<0.001), ASCUS (P=0.005) and normal cytology
(P<0.001). In 58 out of 62 Mycoplasma IST2-positive cases
DNA of U. parvum was demonstrated while in 9 cases (4.9%)
U. urealyticum was detected. In 5 cases both DNAs-U. parvum
and U. urealyticum were detected (Table 2). We detected fewer
instances of U. urealyticum compared to U. parvum, however,
in all but one cases, U. urealyticum biovar 2 strains were iso-
lated from birth canal of women with squamous intraepithe-
lial lesions (Table 2). Among isolated strains of U. parvum
predominance of 3/14 serovar was demonstrated (Table 3). 
Urogenital mycoplasmas were detected significantly more
often in HPV-positive women, compared to HPV-negative
women, 57.5% and 18.3%, respectively. All HSIL and can-
cer cases were HPV-positive. Co-occurrence of selected vagi-
nal microorganisms, including HPV and urogenital mycoplas-
mas, is presented in Table 4. All women included in this study
were C. trachomatis, Neisseria gonorrhoeae and BV-negative.
DISCUSSION
Commercial mycoplasmal kits showed good correlation
with PCR results in detection of Ureaplasma strains, although
it is impossible to differentiate U. parvum and U. urealyticum
using these commercial kits (10, 11). On top of that, urea-
Primer pairs Sequence 5′ -3′ Specifity Amplicon size
UMS57 YAAATCTTAGTGTTCATATTTTTTAC  U. parvum 326 bp
UMA222* GTAAGTGCAGCATTAAATTCAATG  
UMS170 GTATTTGCAATCTTTATATGTTTTCG U. urealyticum 476 bp
UMA 263
� TTTGTTGTTGCGTTTTCTG 
UMS83 TACTGTAGAAATTATGTAAGATTGC U. parvum 398 bp
UMA269* CCAAATGACCTTTTGTAACTAGAT serovar  1
UMS125 GTATTTGCAATCTTTATATGTTTTCG U. parvum 442 bp
UMA269* CCAAATGACCTTTTGTAACTAGAT serovar  3/14
UMS54 CTTAGTGTTCATATTTTTTACTAG U. parvum 369 bp
UMA269* CCAAATGACCTTTTGTAACTAGAT serovar 6
Table 1. Identification of U. parvum and U. urealyticum and subtyping of U. parvum by PCR
*94°C/3 min, 35 cycles 95°C/30 sec; 58
� (55)°C/30 sec, 72°C/60 sec, 72°C/7 min.Urogenital Mycoplasmas in Cervical Dysplasia 1179
arginine broth used in Mycoplasma IST is suitable for isola-
tion of mycoplasmal DNA (12). This is why in the case of
PCR detection we only used samples positive in Mycoplasma
IST2. Our results concerning colonization of 32% of tested
women with Ureaplasma spp. is in accord with other authors,
who demonstrated 20-50% colonization (6, 13-18). How-
ever, Abele-Horn et al. in 1997 (19) described 70% positive
results. Recently published studies from Eastern Poland show
29.8% occurrence of ureaplasmas in non-pregnant women
suffering from urogenital diseases (14). In the case of preg-
nant women in Central Poland this ratio is 26.3% (6). Our
finding of M. hominis (7.7%) is in agreement with our previ-
ously described observations as well as with other authors (13,
15, 17). Domination of U. parvum (86.6%) among isolates
in our study as well as prevalence of serovar 3/14 was in con-
cordance with others (2, 12, 19-22). Co-occurrence of differ-
ent mycoplasmal DNAs and presence of different serovars
of U. parvum in the same sample demonstrated in our study
is in accord with other authors (2, 19, 20). 
Only limited publications are available about relations of
ureaplasmas with ASCUS, LSIL and HSIL. Lukic and cowork-
ers in 2006 (18) described variations in occurrence of Ureaplas-
ma spp. depending of cytological results: in ASCUS -27%,
LSIL -35% and HSIL -45%, compared to women with nor-
mal cytology, 19%. The authors concluded that ureaplasmas
are an important co-factor for HPV. In our study we demon-
strated significantly more frequent occurrence of urogenital
mycoplasmas in the group of women with HSIL: DNA of
HPV was detected in each women in this group. In our pre-
vious studies more frequent isolation of urogenital mycoplas-
mas in the group of women with LSIL infected with HPV,
compared with HPV-negative women, was demonstrated
(13). In the present paper we demonstrated that infection
with high-risk HPV types often accompanied U. urealyticum
88.9%, less frequently U. parvum 67.2%, and rarely it was
confirmed in women without mycoplasmal infection 25.8%.
Several studies demonstrated higher frequency of isolation
of U. parvum compared with U. urealyticum. In our study the
same results were obtained, although percentage of isolated
U. urealyticum was very low. In the present work occurrence
of U. urealyticum (biovar 2) was 4.9%, but was demonstrated
in all but one woman with squamous intraepithelial lesions.
Similar results of low percentage of U. urealyticum were demon-
strated by Japanese authors in preterm birth group 4.8% (22).
ASCUS 
Pathogens
n%
LSIL
n%
HSIL
n%
Cancer
n%
Normal cytology
n%
U. parvum 19 28.4 7 14.3 7 31.8 2 40.0 7 17.9
U. urealyticum 0 0.0 2 4.1 0 0.0 0 0.0 1 2.6
U. parvum+U. urealyticum 0 0.0 2 4.1 1 4.5 0 0.0 0 0.0
U. parvum+U. urealyticum 0 0.0 1 2.0 1 4.5 0 0.0 0 0.0
+M. hominis*
U. parvum+M. hominis* 4 6.0 1 2.0 5 22.7 0 0.0 1 2.6
U. urealyticum+M. hominis* 0 0.0 0 0.0 1 4.5 0 0.0 0 0.0
Total 23 34.3 13 26.5 15 68.2
� 2 40.0 9 23.1
Table 2. Occurrence of urogenital mycoplasmas in study groups (number and percentage of positive cases)
*strains of M. hominis always accompanied ureaplasmas; 
� occurrence of urogenital mycoplasmas in women with HSIL was significantly higher com-
pared with those with LSIL P=0.001, ASCUS P=0.005 and normal cytology P<0.001.
ASCUS, atypical squamous cells of undetermined significance; LSIL, low grade squamous intraepithelial lesions; HSIL, high grade squamous intraep-
ithelial lesions.
Number of strains
Serovar 1
(n=5)
Study groups Serovar
1+3/14
(n=28)
Not
typable
(n=8)
Total
(n=58)
Serovar
3/14
(n=17)
Normal cytology 0 2 5 1 8
ASCUS 2 6 11 4 23
LSIL 1 4 5 1 11
HSIL 1 5 6 2 14
Cancer 1 0 1 0 2
Table 3. Subtyping of isolated Ureaplasma parvum strains (n=58)
ASCUS, atypical squamous cells of undetermined significance; LSIL,
low grade squamous intraepithelial lesions; HSIL, high grade squamous
intraepithelial lesions.
Gram (-)
faculta-
tive rods
Candida
spp.
Lacto-
bacillus
spp.
GBS* HPV
�
U. parvum-positive 67.2 86.2 10.3 6.9 6.9
(n=58)
�
U. urealyticum- 88.9 100 11.1 11.1 11.1
positive (n=9)
�
U. parvum-negative 25.8 83.3 20.0 9.2 14.2
U. urealyticum-negative
M. hominis-negative
(n=120)
Table 4. Co-occurrence (%) of urogenital mycoplasmas and select-
ed vaginal microorganisms (percentage of positive cases)
*GBS-group B streptococci; 
� in 5 cases both U. parvum and U. urealy-
ticum DNAs were detected; 
� HPV, human papillomavirus.
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In many papers U. urealyticum is indicated as the cause of
pathology: in the group of preterm birth women and those
with pelvic inflammatory diseases (19), men with nongono-
coccal and nonchlamydial urethritis (23, 24). Newborns in-
fected with U. urealyticum were subject to more frequent and
longer therapeutic procedures supporting respiration, need-
ed more frequent surfactant and antibiotic administration
(21). However, controversial data are published as to the role
of mycoplasmas in pathogenesis of bronchopulmonary dys-
plasia and chronic lung disease in newborns (14, 20, 25, 26). 
Although our study groups were relatively small, signifi-
cantly higher occurrence of U. urealyticum in women with
squamous intraepithelial lesions suggests a possible role of
this bacterium in pathology. Further investigation using larger
groups of patients are required to demonstrate possible inter-
actions of microorganisms infected female genital tract and
their role in progression of cervical dysplasia.
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